GWAS of Lyme disease identifies five loci and discovers a connection with post-infectious diseases

Abstract

Lyme disease is a vector-borne bacterial infection with marked heterogeneity in susceptibility and clinical manifestations. We investigated the genetic architecture and clinical heterogeneity of Lyme disease using genetic and longitudinal health data from FinnGen and the Estonian Biobank. Genome-wide association analyses included 37,571 individuals with Lyme disease and 670,567 controls (N = 708,138), complemented by sex-stratified analyses and temporal phenotyping in FinnGen.

The overall GWAS meta-analysis identified three genome-wide significant loci at SCGB1D2, TLR1/TLR6, and HLA-DQA1. Sex-stratified analyses identified additional genome-wide significant signals at CPE in males ({beta} = -0.077, P = 2.99 x 10-) and the TYMP-CPT1B locus in females ({beta} = -0.064, P = 4.98 x 10-). The TLR1/6 association was more pronounced in males ({beta} = -0.141, P = 2.16 x 10-{superscript 1}{superscript 2}) than in females ({beta} = -0.060, P = 1.21 x 10-).

Temporal phenotyping showed enrichment of neurological, musculoskeletal, and dermatological manifestations after Lyme disease diagnosis, with associations generally attenuating over time. Bell palsy showed the strongest association at 1-6 months (OR 11.49, P = 2.37 x 10-), while joint pain was also enriched during this interval (OR 1.74, P = 1.95 x 10-{superscript 2}3). Early associations with joint pain and Bell palsy were stronger in males than in females.

These findings expand the genetic architecture of Lyme disease, implicate innate immune sensing through the TLR1/TLR6 locus, and antigen presentation through the HLA associations. Overall, the results highlight a strong polygenic signal with Lyme disease and a connection with other post-infectious clinical manifestations.

Benchmarking time series foundation models for multi-country infectious disease forecasting: a retrospective evaluation across over 70 diseases
Peng Cai, Guoyu Huang, Ximing Xu
BMC Public Health14 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Avina Vongpradith, Regina-Mae Villanueva Dominguez, Lorainne Tudor Car +97
The Lancet Infectious Diseases2 Jun 2026Peer-reviewedLicence not statedFull text24 citedInfectious diseaseOpenAlex
Accelerating drug development in infectious diseases using zebrafish disease models supported by pharmacokinetic pharmacodynamic modeling as new approach methodology (NAM)
G. Forn-Cuni, B. van Lieshout, B. Koch +11
bioRxiv29 May 2026PreprintCC BYFull text1 citedPharmacology & toxicologybioRxiv
Hospital-treated infectious diseases, infection burden, and subsequent risk of demyelinating diseases: a prospective cohort study
Q. Chen, Y. Shen, Y. Chen +1
medRxiv23 Oct 2026PreprintAll rights reservedFull textNeurologymedRxiv
Digital Footprint and Audience Engagement Among Infectious Diseases Medical Educators on TikTok
Saira Butt
Cureus16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX RIS

BibTeX

@misc{strausz2026gwas,
  title = {{GWAS of Lyme disease identifies five loci and discovers a connection with post-infectious diseases}},
  author = {S. Strausz and E. Romppanen and H. Haapaniemi and FinnGen and Estonian Biobank Research team and Health Informatics Research Team and R. Saxena and N. Sinnit-Armstrong and E. Abner and H. M. Ollila},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.21.26366124},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.21.26366124v1},
  note = {CC BY-NC-ND},
}

RIS

TY  - UNPB
TI  - GWAS of Lyme disease identifies five loci and discovers a connection with post-infectious diseases
AU  - S. Strausz
AU  - E. Romppanen
AU  - H. Haapaniemi
AU  - FinnGen
AU  - Estonian Biobank Research team
AU  - Health Informatics Research Team
AU  - R. Saxena
AU  - N. Sinnit-Armstrong
AU  - E. Abner
AU  - H. M. Ollila
PY  - 2026
DA  - 2026/10/21
PB  - medRxiv
DO  - 10.64898/2026.10.21.26366124
UR  - https://www.medrxiv.org/content/10.64898/2026.10.21.26366124v1
AB  - Lyme disease is a vector-borne bacterial infection with marked heterogeneity in susceptibility and clinical manifestations. We investigated the genetic architecture and clinical heterogeneity of Lyme disease using genetic and longitudinal health data from FinnGen and the Estonian Biobank. Genome-wide association analyses included 37,571 individuals with Lyme disease and 670,567 controls (N = 708,138), complemented by sex-stratified analyses and temporal phenotyping in FinnGen.  The overall GWAS meta-analysis identified three genome-wide significant loci at SCGB1D2, TLR1/TLR6, and HLA-DQA1. Sex-stratified analyses identified additional genome-wide significant signals at CPE in males ({beta} = -0.077, P = 2.99 x 10-) and the TYMP-CPT1B locus in females ({beta} = -0.064, P = 4.98 x 10-). The TLR1/6 association was more pronounced in males ({beta} = -0.141, P = 2.16 x 10-{superscript 1}{superscript 2}) than in females ({beta} = -0.060, P = 1.21 x 10-).  Temporal phenotyping showed enrichment of neurological, musculoskeletal, and dermatological manifestations after Lyme disease diagnosis, with associations generally attenuating over time. Bell palsy showed the strongest association at 1-6 months (OR 11.49, P = 2.37 x 10-), while joint pain was also enriched during this interval (OR 1.74, P = 1.95 x 10-{superscript 2}3). Early associations with joint pain and Bell palsy were stronger in males than in females.  These findings expand the genetic architecture of Lyme disease, implicate innate immune sensing through the TLR1/TLR6 locus, and antigen presentation through the HLA associations. Overall, the results highlight a strong polygenic signal with Lyme disease and a connection with other post-infectious clinical manifestations.
ER  -

Abstract

Related

Cite